-
ICD-10-CM Codes
›
-
C00-D49
Neoplasms
›
-
C7B-C7B
Secondary neuroendocrine tumors
›
-
C7B-
Secondary neuroendocrine tumors
›
-
2021 ICD-10-CM Diagnosis Code C7B.09
2021 ICD-10-CM Diagnosis Code C7B.09
Secondary carcinoid tumors of other sites
2016 2017 2018 2019 2020 2021 Billable/Specific Code
- C7B.09 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2021 edition of ICD-10-CM C7B.09 became effective on October 1, 2020.
- This is the American ICD-10-CM version of C7B.09 - other international versions of ICD-10 C7B.09 may differ.
The following code(s) above
C7B.09 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
C7B.09:
ICD-10-CM C7B.09 is grouped within Diagnostic Related Group(s) (MS-DRG v38.0):
- 826 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures with mcc
- 827 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures with cc
- 828 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures without cc/mcc
- 829 Myeloproliferative disorders or poorly differentiated neoplasms with other procedures with cc/mcc
- 830 Myeloproliferative disorders or poorly differentiated neoplasms with other procedures without cc/mcc
- 843 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with mcc
- 844 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with cc
- 845 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses without cc/mcc
Convert C7B.09 to ICD-9-CM
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
ICD-10-CM Codes Adjacent To C7B.09
C7A.098 Malignant carcinoid tumors of other sites
C7A.1 Malignant poorly differentiated neuroendocrine tumors
C7A.8 Other malignant neuroendocrine tumors
C7B Secondary neuroendocrine tumors
C7B.0 Secondary carcinoid tumors
C7B.01 …… of distant lymph nodes
C7B.09
…… of other sites
C7B.1 Secondary Merkel cell carcinoma
C7B.8 Other secondary neuroendocrine tumors
C76 Malignant neoplasm of other and ill-defined sites
C76.0 Malignant neoplasm of head, face and neck
C76.1 Malignant neoplasm of thorax
C76.2 Malignant neoplasm of abdomen
C76.3 Malignant neoplasm of pelvis
C76.4 Malignant neoplasm of upper limb
C76.40 Malignant neoplasm of unspecified upper limb
C76.41 Malignant neoplasm of right upper limb
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.